iHateHospitals.com

MEDICAL NEWS:
Abstract

Background  Physicians, influenced by various pressures, may document information in patient records that they did not personally observe.

Objective  To evaluate the hospital chart documentation practices of internists and internal medicine sub-specialists in the Northeastern
United States.

Design  An anoNY (New York)mous mail survey questionnaire.

Participants  One thousand one hundred twenty-six randomly selected internists and internal medicine sub-specialists.
[...]

MEDICAL NEWS:
Abstract

Background  African-American women have the highest breast (boob) cancer death rates of all racial/ethnic groups in the US. Reasons for these
disparities are multi-factorial, but include lower mammogram utilization among this population. Cultural attitudes and beliefs,
such as fear and fatalism, have not been fully explored as potential barriers to mammography among African-American women.

Objective  To [...]

MEDICAL NEWS:
Brief Report: Coronary Heart Disease Events Associated with Hormone Therapy in Younger and Older Women

Content Type Journal Article
Category Erratum
DOI 10.1007/s11606-008-0762-2
Authors

Shelley R. Salpeter, Santa Clara Valley Medical Center Department of Medicine San Jose CA USA
Judith M. E. Walsh, University of California, San Francisco Department of Medicine San Francisco CA USA
Elizabeth Greyber, Santa Clara Valley Medical [...]

CANCER NEWS: The hypothesis that cancer stem cells are responsible for the chemo-resistant and metastatic phenotypes of many breast (women’s) cancers has gained support using cell sorting strategies to enrich for the tumor-initiating population of cells. However, the mechanisms regulating the cancer stem cell pool are less clear. Two recent publications suggest that loss [...]

CANCER NEWS: Not all doctors email patients, nor for that matter do all doctors email each other - but I have found it to be helpful for many patients. Not all patients have my email account, but for some patients for whom it seems appropriate I have given out my office email adDr. [...]

CANCER NEWS: Australian scientists have identified a way to ’switch off’ a molecule, a key player in the molecular processes that trigger breast (women’s) cancer and certain forms of leukemia. The molecule, known as Gab2, operates downstream of a major breast (women’s) cancer oncogene, HER2, the target of the Dr. (God)g Herceptin. A research [...]

CANCER NEWS: COPENHAGEN, Denmark — Genmab has announced plans to begin four studies of ofatumumab in chronic lymphocytic leukemia and non-Hodgkin’s lymphoma. Genmab A/S announced today plans to begin four studies of ofatumumab in chronic lymphocytic leukemia (CLL) and follicular non-Hodgkin’s lymphoma (NHL) this year. “Genmab and GSK have worked diligently to expand the [...]

CANCER NEWS: Two vaccines against a virus that can cause cervical cancer are being widely used without sufficient evidence about whether they are worth their high cost or whether they will effectively stop women from getting the disease, two articles in this week’s New England Journal of Medicine conclude. Both vaccines target the human [...]

(Mesothelioma News) ROCKVILLE, Md. — Human Genome Sciences, Inc. today announced that it has completed the enrollment and initial dosing of patients in a randomized Phase 2 trial of HGS-ETR1 (mapatumumab) in combination with the chemotherapy (serious, serious drugs) agents paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer (NSCLC). “There is [...]

DRUGS & RX: INDIANAPOLIS, August 26, 2008 /PRNewswire/ — Semafore Pharmaceuticals Inc. presented data at the Seventh International Congress on Targeted Therapies in Cancer in Washington, D.C., announcing the discovery of novel multi-targeted kinase inhibitors…

View the source of this article…

Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors was another wonderful and informative drug and pharmaceutical article [...]

DRUGS & RX: INDIANAPOLIS, August 26, 2008 /PRNewswire/ — Semafore Pharmaceuticals Inc. announced data presented at the Seventh International Congress on Targeted Therapies in Cancer in Washington, D.C., showing additional antiangiogenic activity of…

View the source of this article…

SF1126, Semafore’s PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell [...]

DRUGS & RX: NICE Final Guidance Recommends Lucentis As Cost-Effective Treatment for Wet AMD, a Leading Cause of Blindness
Lucentis is only approved therapy to demonstrate improvement in vision and vision-related function in vast majority of wet AMD…

View the source of this article…

NICE Final Guidance Recommends Lucentis As Cost-Effective Treatment for Wet AMD was another wonderful [...]